http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2180225-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8b4c282fd538ef138689e725513319c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
filingDate 1999-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19bef5e06789e38662ea8509f89e657e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6abb013b2758a55972cbf885cca8e8b0
publicationDate 2002-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2180225-C2
titleOfInvention Method for treating severe bronchial asthma patients by applying glucocorticoid chronotherapy
abstract FIELD: medicine. SUBSTANCE: method involves administering glucocorticoid preparations according to a scheme relative to three selected types of cortisol production with suprarenal gland as of morning, daytime and evening one. EFFECT: enhanced effectiveness in revealing suprarenal gland functioning sychronization disorders; enhanced effectiveness of long-term systemic therapy including glucocorticoid preparation application.
priorityDate 1999-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265

Total number of triples: 19.